{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:06:49Z","timestamp":1792206409467,"version":"4.4.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Thrombotic thrombocytopenic purpura (TTP) is a rare, potentially fatal thrombotic microangiopathy caused by severe ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin motif 13) deficiency. Prompt treatment improves survival; however, reference standard enzyme-linked immunosorbent assay and FRETS-VWF73 ADAMTS13 activity assays have long turnaround times (TATs) that necessitate empiric treatment of many patients who ultimately are found not to have TTP. Rapid assays with analytical TATs &amp;lt;1 hour have recently become available. We conducted a systematic review and meta-analysis of the performance characteristics of rapid assays relative to reference standard assays for ADAMTS13 activity for patients with suspected or confirmed TTP. Nineteen studies representing 3 rapid ADAMTS13 assays and 4207 patient samples were included. The HemosIL AcuStar chemiluminescence immunoassay (CLIA) demonstrated high sensitivity (0.98; 95% confidence interval [CI], 0.94-1.00), specificity (0.99; 95% CI, 0.97-1.00), and positive (PPV) (0.96; 95% CI, 0.90-0.98) and negative predictive values (NPV) (0.99; 95% CI, 0.99-1.00). The Technofluor fluorescence resonance energy transfer (FRET) and Technoscreen assays had sensitivity of 0.93 (95% CI, 0.86-0.96) and 0.98 (95% CI, 0.42-1.00), specificity of 0.98 (95% CI, 0.95-0.99) and 0.87 (95% CI, 0.76-0.94), PPV of 0.97 (95% CI, 0.85-1.00) and 0.71 (95% CI, 0.59-0.80), and NPV of 0.96 (95% CI, 0.93-0.98) and 0.99 (95% CI, 0.72-1.00), respectively. The proportion of discrepant results (relative to reference standard assays) was 0.04 (95% CI, 0.03-0.05) for HemosIL AcuStar, 0.04 (95% CI, 0.02-0.06) for Technofluor FRET, and 0.11 (95% CI, 0.07-0.16) for the Technoscreen assay. With rapid TAT and high sensitivity, the HemosIL AcuStar CLIA seems able to reliably avert empiric plasma exchange, corticosteroids, and caplacizumab in patients without TTP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025028416","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T15:29:42Z","timestamp":1745249382000},"page":"233-246","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Rapid ADAMTS13 activity assays for thrombotic thrombocytopenic purpura: a systematic review and meta-analysis"],"prefix":"10.1182","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9824-9052","authenticated-orcid":false,"given":"Saarang R.","family":"Deshpande","sequence":"first","affiliation":[{"name":"1Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemza","family":"Tarawneh","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Deitelzweig","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Tong","sequence":"additional","affiliation":[{"name":"2Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD"},{"name":"3Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3392-2979","authenticated-orcid":false,"given":"Ting","family":"Zhou","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"4Department of Biostatistics, Epidemiology, and Informatics, The Center for Health AI and Synthesis of Evidence, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0835-0788","authenticated-orcid":false,"given":"Yong","family":"Chen","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"4Department of Biostatistics, Epidemiology, and Informatics, The Center for Health AI and Synthesis of Evidence, University of Pennsylvania, Philadelphia, PA"},{"name":"5The Graduate Group in Applied Mathematics and Computational Science, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-5697","authenticated-orcid":false,"given":"Adam","family":"Cuker","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"6Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"21","key":"2025071011261799900_bib1","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"issue":"6855","key":"2025071011261799900_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"issue":"10","key":"2025071011261799900_bib3","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2025071011261799900_bib4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/trf.15721","article-title":"Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura","volume":"60","author":"Colling","year":"2020","journal-title":"Transfusion (Paris)"},{"key":"2025071011261799900_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.thromres.2020.05.045","article-title":"Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: a 10-year provincial retrospective cohort study","volume":"193","author":"Sawler","year":"2020","journal-title":"Thromb Res"},{"issue":"4","key":"2025071011261799900_bib6","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"issue":"4","key":"2025071011261799900_bib7","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA Reference Center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS ONE"},{"issue":"3","key":"2025071011261799900_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0040-1708541","article-title":"Immune-mediated thrombotic thrombocytopenic purpura: a narrative review of diagnosis and treatment in adults","volume":"46","author":"Blennerhassett","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"2025071011261799900_bib9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ajh.26241","article-title":"Laboratory testing for ADAMTS13: utility for TTP diagnosis\/exclusion and beyond","volume":"96","author":"Favaloro","year":"2021","journal-title":"Am J Hematol"},{"key":"2025071011261799900_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/978-1-0716-3175-1_31","volume-title":"Hemostasis and Thrombosis. Methods in Molecular Biology","author":"Favaloro","year":"2023","edition":"2nd ed"},{"issue":"6","key":"2025071011261799900_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/ijlh.13295","article-title":"International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13","volume":"42","author":"Mackie","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"2025071011261799900_bib12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1055\/s-0038-1641151","article-title":"Evaluation of the fully automated HemosIL Acustar ADAMTS13 activity assay","volume":"118","author":"Favresse","year":"2018","journal-title":"Thromb Haemost"},{"issue":"suppl 1","key":"2025071011261799900_bib13","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2019-128131","article-title":"Faster diagnosis of TTP using new Technoscreen Adamts-13 activity assay [abstract]","volume":"134","author":"Braf","year":"2019","journal-title":"Blood"},{"issue":"2","key":"2025071011261799900_bib14","doi-asserted-by":"crossref","first-page":"100108","DOI":"10.1016\/j.rpth.2023.100108","article-title":"ADAMTS13 activity testing: evaluation of commercial platforms for diagnosis and monitoring of thrombotic thrombocytopenic purpura","volume":"7","author":"Singh","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"10","key":"2025071011261799900_bib15","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2014-10-559211","article-title":"The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura","volume":"125","author":"Lim","year":"2015","journal-title":"Blood"},{"issue":"15","key":"2025071011261799900_bib16","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.3390\/jcm13154462","article-title":"Practical considerations for the use of the rapid AcuStar\u00ae ADAMTS13 activity assay in the diagnosis of acute thrombotic thrombocytopenic purpura (TTP)","volume":"13","author":"Yong","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"2025071011261799900_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/jalm\/jfab148","article-title":"Diagnosis of thrombotic thrombocytopenic purpura by ADAMTS13 activity quantification","volume":"7","author":"Dimopoulos","year":"2022","journal-title":"J Appl Lab Med"},{"issue":"1","key":"2025071011261799900_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/rth2.12461","article-title":"Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay","volume":"5","author":"Beranger","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"2025071011261799900_bib19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"2025071011261799900_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/ijlh.14077","article-title":"A multicenter evaluation of the Technoscreen ADAMTS13 activity semi-quantitative screening test for thrombotic thrombocytopenic purpura diagnosis and exclusion","volume":"45","author":"Stephenson","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"2025071011261799900_bib21","unstructured":"Covidence Systematic Review Software. Veritas Health Innovation. Accessed 30 May 2024. www.covidence.org."},{"issue":"8","key":"2025071011261799900_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"10","key":"2025071011261799900_bib23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2025071011261799900_bib24","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jclinepi.2006.06.011","article-title":"Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach","volume":"59","author":"Chu","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2025071011261799900_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"2025071011261799900_bib26","unstructured":"Gordon\n              M\n            , LumleyT. Advanced Forest Plot Using \u201cgrid\u201d Graphics. R Package Version 3.1.6. GitHub. Accessed 6 June 2024. https:\/\/github.com\/gforge\/forestplot."},{"issue":"7414","key":"2025071011261799900_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"2025071011261799900_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"issue":"10","key":"2025071011261799900_bib29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/bloodadvances.2017005124","article-title":"Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015","volume":"1","author":"Page","year":"2017","journal-title":"Blood Adv"},{"issue":"1","key":"2025071011261799900_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"5","key":"2025071011261799900_bib31","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1515\/cclm-2020-1020","article-title":"Comparative evaluation of the fully automated HemosIL\u00ae AcuStar ADAMTS13 activity assay vs. ELISA: possible interference by autoantibodies different from anti ADAMTS-13","volume":"59","author":"Falcinelli","year":"2021","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"2025071011261799900_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jth.15157","article-title":"A multicenter laboratory assessment of a new automated chemiluminescent assay for ADAMTS13 activity","volume":"19","author":"Favaloro","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"2025071011261799900_bib40","first-page":"553","article-title":"Multi-centre performance evaluation of ADAMTS13 activity quantification using three different measurement technologies [abstract]","volume":"6","author":"Foxton","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"suppl 1","key":"2025071011261799900_bib33","first-page":"937","article-title":"Evaluation of a rapid, automated chemiluminescent ADAMTS-13 activity assay for the ACL AcuStar [abstract]","volume":"4","author":"Fretwell","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"2025071011261799900_bib41","unstructured":"Fretwell\n              RE\n            , PitchfordT, KitchenS. PB0304 - Evaluation of an automated FRET based ADAMTS-13 activity assay. Accessed 30 May 2024. https:\/\/isth2024.eventscribe.net\/searchGlobal.asp."},{"issue":"5","key":"2025071011261799900_bib34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/ijlh.14090","article-title":"Evaluation of two fully automated ADAMTS13 activity assays in comparison to manual FRET assay","volume":"45","author":"Irsara","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"2025071011261799900_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.rpth.2023.101464","article-title":"Prospective evaluation of the HemosIL AcuStar ADAMTS13 activity assay","volume":"7","author":"Mancini","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"7","key":"2025071011261799900_bib42","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/jth.14815","article-title":"A multi-center evaluation of TECHNOSCREEN\u00ae ADAMTS-13 activity assay as a screening tool for detecting deficiency of ADAMTS-13","volume":"18","author":"Moore","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2025071011261799900_bib36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/ijlh.13414","article-title":"Multicentric evaluation of the new HemosIL Acustar\u00ae chemiluminescence ADAMTS13 activity assay","volume":"43","author":"Pascual","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"2025071011261799900_bib37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s11239-020-02086-8","article-title":"Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study","volume":"50","author":"Stratmann","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"suppl 1","key":"2025071011261799900_bib38","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2022-163471","article-title":"Rapid diagnosis of acute thrombotic thrombocytopenic purpura (TTP) using a new fully automated chemiluminescent assay for Adamts-13 activity. Clinical performance and cost-effectiveness analysis [abstract]","volume":"140","author":"Toulon","year":"2022","journal-title":"Blood"},{"issue":"11","key":"2025071011261799900_bib39","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1055\/s-0039-1696718","article-title":"Evaluation of a new, rapid, fully automated assay for the measurement of ADAMTS13 activity","volume":"119","author":"Valsecchi","year":"2019","journal-title":"Thromb Haemost"},{"issue":"10","key":"2025071011261799900_bib43","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.15010","article-title":"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2025071011261799900_bib44","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/trf.13359","article-title":"Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura","volume":"56","author":"Connell","year":"2016","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"2025071011261799900_bib45","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ijlh.13372","article-title":"Inhibitory anti ADAMTS13 antibodies with a new rapid fully automated CLiA assay","volume":"43","author":"Montaruli","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"9","key":"2025071011261799900_bib46","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/bloodadvances.2024012608","article-title":"Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura","volume":"8","author":"Allen","year":"2024","journal-title":"Blood Adv"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/2\/233\/2402456\/blood_bld-2025-028416-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/2\/233\/2402456\/blood_bld-2025-028416-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T15:26:29Z","timestamp":1752161189000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/2\/233\/536852\/Rapid-ADAMTS13-activity-assays-for-thrombotic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025028416","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,10]]},"published":{"date-parts":[[2025,7,10]]}}}